Complement-Based Drug Development Summit leaderboard
  • Friday, September 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 530

Author

Pharma Journalist 9038 posts 0 comments

VBI Vaccines Announces Tie-up To Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS,…

Apr 1, 2020
VBI Vaccines Inc. announced a collaboration with the National Research Council of Canada (NRC), Canada’s largest federal research and development organization, to develop a…
Read More...

Ostrich Pharma USA Produces Antibodies to Block the Virus that Causes COVID-19

Mar 31, 2020
Ostrich Pharma USA has announced the successful development of ostrich antibodies to the SARS-CoV-2 virus, the expanding use of those antibodies in Japan, and plans for producing and…
Read More...

AstraZeneca’s Lokelma recommended for approval in EU for patients with hyperkalaemia on stable…

Mar 31, 2020
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on a dosing and administration label update for…
Read More...

ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology

Mar 31, 2020
ImaginAb Inc. announced that it has signed a multi-year non-exclusive license agreement with AstraZeneca. Under the terms of the agreement, ImaginAb's CD8 ImmunoPET technology will…
Read More...

Altimmune And The University Of Alabama At Birmingham To Collaborate On Development Of Single-Dose,…

Mar 31, 2020
Altimmune, Inc., announced that it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its single-dose, intranasal COVID-19 vaccine,…
Read More...

Noveome Launches Program to Evaluate ST266 for the Treatment of the Severe Inflammatory Response…

Mar 31, 2020
Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or…
Read More...

GigaGen Initiates Development of Recombinant Polyclonal Antibody Therapy for COVID-19

Mar 31, 2020
GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced it has been…
Read More...

Aptorum Group and Covar Pharmaceuticals explore repurposed drugs for coronavirus

Mar 31, 2020
Aptorum Group Limited, a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease…
Read More...

Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine

Mar 31, 2020
Cobra Biologics and the Karolinska Institutet announced they have been awarded €3million emergency funding by Horizon 2020 for research and development, and phase I clinical trial…
Read More...

Sorrento Enters Preclinical Testing Agreement For COVID-19 Candidates

Mar 31, 2020
Sorrento Therapeutics, Inc. announced it has entered into a research testing agreement with The University of Texas Medical Branch at Galveston for the preclinical testing of Sorrento’s…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.